LONDON (MarketWatch) -- Pittsburgh drug maker Mylan said it priced its 1.86 million convertible preferred stock offering at $1,000 per share and its 53.5 million common stock offering at $14 a share.

Shares of Mylan (NYSE:MYL) plunged in Wednesday trading after the company reported disappointing fourth-quarter results. Mylan stock fell as much as 15% as a result and made new 52-week lows. This ...

NEW YORK (MarketWatch) -- Mylan Laboratories myl Friday priced an offering of senior convertible notes and common stock that it expects to yield total gross proceeds of $993.6 million.

Mylan’s life-saving EpiPen injection device is not the only medication in the company’s portfolio that has seen large price spikes, reports NBC News. In June, Wells Fargo Senior Analyst David Maris ...

This Oct. 10, 2013 file photo shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. (AP Photo/Mark Zaleski, File) NEW YORK • Dutch drugmaker Mylan says it will launch a ...

TRENTON, N.J. — Generic drug giant Teva formally offered to buy fellow drugmaker Mylan for about $40.1 billion in cash and stock on Tuesday, despite Mylan’s cold shoulder and the certainty the ...

BOSTON (Reuters) - U.S. regulators have begun investigating possible manufacturing violations by Mylan Inc , the world's third-biggest generic drugmaker. Shares of Mylan fell 13 percent on Monday ...